Obudanersen
RNA / oligonucleotide
Evidence outlook · registrational
Angelman Syndrome: registrational readout pending
No completed mid-stage readout is on record. Registrational readout expected around 2027-08.
How the evidence outlook works ↗
Featured trials
The studies most instrumental to this drug's clinical progression, individually graded on design and result. The complete registry, including every study not featured here, is listed below.
| Trial | Phase | Endpoint | Key result | Signal | Source |
|---|---|---|---|---|---|
NCT05127226 NCT05127226 · Angelman Syndrome Registry: NCT05127226 | 1/2 | To evaluate the safety and tolerability of single and multiple doses of ION582 (incidence, severity, and dose-relationship of adverse effects and changes in the laboratory parameters). (Part 1: Up to Week 45; Part 2: Up to Week 81) 2032-03 | In progress: results expected 1 Mar 2029 | not yet graded | link ↗ |
View 2 more trials
NCT07782827 NCT07782827 · Angelman Syndrome Registry: NCT07782827 | 3 | Change From Baseline in Performance on the Expressive Communication Domain Raw Score Without Caregiver Input of the Bayley Scales for Infant and Toddler Development-4 (Bayley-4) in Cohort 1 (Baseline and Week 52) 2028-05 | In progress: results expected 1 May 2028 | not yet graded | link ↗ |
NCT06914609 NCT06914609 · Angelman Syndrome Registry: NCT06914609 | 3 | Change in Performance on the Expressive Communication Subdomain Raw Score of the Bayley Scales for Infant and Toddler Development-4 (Bayley-4) Without Caregiver Input in Cohort 1 (Baseline and Week 52) 2027-08 | In progress: results expected 1 Aug 2027 | not yet graded | link ↗ |
All registered studies
Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded. Filter by which indication a study was run for, then browse by phase.
Phase 3 (2)
What this study did
What this study did
Phase 1/2 (1)
What this study did
Competitive landscape
No competitors sharing a mechanism or indication in the current universe.
Upcoming events
(3 total)
Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.
Follow Obudanersen to get an email as a readout nears, when a date moves, or when a study changes status. Needs a free account.
Add these readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.